JOINT Corp (JYNT) Earnings History

JOINT Corp - Q3 FY2025 Earnings

Filed at: Nov 6, 2025, 3:09 PM EST|Read from source

EXECUTIVE SUMMARY

The Joint Corp. reported improved profitability and revenue growth in Q3 2025, driven by strategic initiatives and operational enhancements, though system-wide sales and comp sales showed a slight decline.

POSITIVE HIGHLIGHTS

  • •

    Revenue grew 6% to $13.4 million compared to Q3 2024.

    positive
  • •

    Net income from continuing operations improved to $290,000 from a net loss of $414,000 in Q3 2024.

    positive
  • •

    Adjusted EBITDA from continuing operations increased significantly to $1.4 million from $262,000 in Q3 2024.

    positive
  • •

    Board authorized an additional $12 million for share repurchases, indicating confidence in future growth.

    positive
  • •

    Sold eight franchise licenses, up from seven in Q3 2024.

    positive

CONCERNS & RISKS

  • •

    System-wide sales declined 1.5% to $127.3 million.

    negative
  • •

    Comparable sales decreased by 2.0%.

    negative
  • •

    Selling and marketing expenses increased 13% due to digital marketing transformation efforts.

    attention
  • •

    Full financial benefit of strategic initiatives will take time to come to fruition.

    attention

FINANCIAL METRICS

Revenue
Quarterly
$13.38M
+5.7%
Prior year: $12.65M
Net Income
Quarterly
$855.01K
N/A
Prior year: $-3.17M
EPS (Diluted)
Quarterly
$0.06
N/A
Prior year: $-0.21
Operating Income
Quarterly
$160.91K
N/A
Prior year: $-492.82K
EPS (Basic)
Quarterly
$0.06
N/A
Prior year: $-0.21

MARGIN ANALYSIS

Operating Margin
Current Quarter
1.2%
Prior Year
-3.9%
YoY Change
+510 bps
Net Margin
Current Quarter
6.4%
Prior Year
-25.0%
YoY Change
+3140 bps

Margin expansion indicates improving profitability and operational efficiency. Measured in basis points (bps): 100 bps = 1.0%.

MANAGEMENT GUIDANCE

FY 2025

system_wide_sales
$530000.0B—$534000.0B
Mid-point: $532000.0B
"Updated from prior guidance of $530M to $550M."
comp_sales
$-1.0M—$0.0M
Mid-point: $-0.5M
"Updated from prior guidance of an increase in the low-single digit range."
consolidated_adjusted_ebitda
10,800,000—11,800,000
Mid-point: 11,300,000
"Guidance range remains the same."
new_clinic_openings
30—35
Mid-point: 32.5
"Guidance range remains the same."

Forward-looking guidance is subject to change and does not constitute a guarantee. Actual results may differ materially from these estimates.

MANAGEMENT COMMENTARY

Strengthened management team and executed strategies to refranchise corporate portfolio, drive new patient acquisition, grow system-wide sales, and improve comp sales and operating leverage.

— JOINT Corp, Q3 FY2025 2025 Earnings Call

Brand message transitioned toward pain management, to be amplified by shifting advertising spend to national media.

— JOINT Corp, Q3 FY2025 2025 Earnings Call

Investing in search engine optimization to leverage AI-search and more impactful clinic microsite content.

— JOINT Corp, Q3 FY2025 2025 Earnings Call

Commentary excerpts from earnings call transcripts provide management's perspective on performance, strategy, and outlook. Always review full transcripts for complete context.

OPERATIONAL METRICS

Company Owned Clinics Closed
3
clinics
Company Owned Managed Clinic Count
78
clinics
Franchise Licenses Sold
8
+14.3% YoY
Prior year: 7
licenses
Franchised Clinic Count
884
clinics
Franchised Clinics Closed
11
clinics
Franchised Clinics Opened
9
clinics
Total Clinic Count
962
clinics

Operational metrics provide insight into business drivers and customer engagement beyond traditional financial measures.